{"id":904356,"date":"2025-11-03T11:35:01","date_gmt":"2025-11-03T16:35:01","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/co-diagnostics-to-integrate-and-implement-proprietary-artificial-intelligence-technology-into-co-dx-primer-ai-platform\/"},"modified":"2025-11-03T11:35:01","modified_gmt":"2025-11-03T16:35:01","slug":"co-diagnostics-to-integrate-and-implement-proprietary-artificial-intelligence-technology-into-co-dx-primer-ai-platform","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/co-diagnostics-to-integrate-and-implement-proprietary-artificial-intelligence-technology-into-co-dx-primer-ai-platform\/","title":{"rendered":"Co-Diagnostics to Integrate and Implement Proprietary Artificial Intelligence Technology into Co-Dx\u2122 Primer Ai\u2122 Platform"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n Company forms new AI business unit, led by Chief Technology & AI Officer Christopher Thurston<\/span>, to unify and advance Co-Dx’s existing and future AI initiatives <\/i>\n <\/p>\n

\n
\n SALT LAKE CITY<\/span>
\n <\/span>, Nov. 3, 2025<\/span><\/span> \/PRNewswire\/ — Co-Diagnostics, Inc.\u00a0(Nasdaq: CODX) (the “Company” or “Co-Dx”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced the formation of a newly organized, artificial intelligence (“AI”) business unit, led by Chief Technology & AI Officer Christopher Thurston<\/span>, to integrate the Company’s existing and planned AI applications into the Co-Dx\u2122 Primer Ai\u2122 platform.<\/p>\n

\n

\n
\n \"(PRNewsfoto\/Co-Diagnostics)\"
\n <\/a>\n <\/p>\n<\/p><\/div>\n

Co-Dx anticipates that allocating resources to the newly formed AI business unit will enable the Company to develop proprietary AI-powered diagnostics more efficiently and reduce time-to-market for new tests. The Company also believes that future AI tools will be able to leverage the analytics yielded from widespread deployment and commercialization of the Co-Dx PCR Pro* to improve situational awareness during a health crisis, and potentially predict outbreaks and pandemics before they occur.<\/p>\n

“Since our founding in 2013, Co-Diagnostics has been at the forefront of PCR technology innovation, beginning with the introduction of the revolutionary Co-Primers\u00ae technology, and later with the development of the Co-Dx PCR platform to help close the diagnostics access gap,” remarked Dwight Egan<\/span>, Co-Dx Chief Executive Officer. “Now, as the rate of adoption of enterprise artificial intelligence increases and AI applications continue to grow in ubiquity and utility, we have begun incorporating these next-generation tools to help increase operational efficiency, minimize human error, improve outcomes in real-time point-of-care testing, and truly give physicians, patients, and communities the Power to Know\u2122.”<\/p>\n

The Company’s next-generation diagnostics technology, enhanced by proprietary AI models, enables real-time PCR diagnostics at the point-of-care. Co-Dx’s AI models support internal data and workflow orchestration, as well as Co-Primers design and optimization. Future models will enhance automated test interpretation and create predictive epidemiological awareness. These models will operate in tandem with the Company’s HIPAA-compliant Co-Dx cloud platform and internal databases to form the foundation of Co-Dx Primer Ai.<\/p>\n

\n
\n *The Co-Dx PCR platform (including the Co-Dx PCR Home\u2122, Co-Dx PCR Pro\u2122, mobile app, and all associated tests and software) is subject to review by the FDA and\/or other regulatory bodies and is not available for sale.<\/u>
\n <\/i>\n <\/p>\n

\n About Co-Diagnostics, Inc.:
<\/b>Co-Diagnostics, Inc., a Utah<\/span> corporation, is a molecular diagnostics company that develops, manufactures and markets state-of-the-art diagnostics technologies. The Company’s technologies are utilized for tests that are designed to detect and\/or analyze nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR at-home and point-of-care platform (subject to regulatory review and not currently for sale) and to identify genetic markers for use in applications other than infectious disease.<\/p>\n

\n
\n Forward-Looking Statements:
<\/i>
\n <\/b>
\n This press release contains forward-looking statements. Forward-looking statements can be identified by words such as “believes,” “expects,” “estimates,” “intends,” “may,” “plans,” “will” and similar expressions, or the negative of these words. Such forward-looking statements are based on facts and conditions as they exist at the time such statements are made and predictions as to future facts and conditions. Forward-looking statements in this release include statements regarding the Company’s expectations that the formation of its AI business unit will enable more efficient development of proprietary AI-powered diagnostics, improve situational awareness, and reduce time-to-market for new tests; the belief that future AI tools and models will leverage analytics from deployment of the Co-Dx PCR Pro\u2122 platform to improve outbreak prediction and real-time awareness; anticipated benefits of incorporating next-generation AI tools to increase operational efficiency, minimize human error, and improve point-of-care outcomes; and expectations regarding future regulatory review and potential commercialization of the Co-Dx PCR platform and related products.. Actual results may differ materially from those contemplated or anticipated by such forward-looking statements. Readers of this press release are cautioned not to place undue reliance on any forward-looking statements. There can be no assurance that any of the anticipated results will occur on a timely basis or at all due to certain risks and uncertainties, a discussion of which can be found in our Risk Factors disclosure in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (SEC) on March 27, 2025<\/span>, and in our other filings with the SEC. The Company does not undertake any obligation to update any forward-looking statement relating to matters discussed in this press release, except as may be required by applicable securities laws.<\/i>\n <\/p>\n

\u00a0<\/p>\n

\n \"Cision\" View original content to download multimedia:https:\/\/www.prnewswire.com\/news-releases\/co-diagnostics-to-integrate-and-implement-proprietary-artificial-intelligence-technology-into-co-dx-primer-ai-platform-302602287.html<\/a><\/p>\n

SOURCE Co-Diagnostics<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

PR Newswire Company forms new AI business unit, led by Chief Technology & AI Officer Christopher Thurston, to unify and advance Co-Dx’s existing and future AI initiatives SALT LAKE CITY , Nov. 3, 2025 \/PRNewswire\/ — Co-Diagnostics, Inc.\u00a0(Nasdaq: CODX) (the “Company” or “Co-Dx”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced the formation of a newly organized, artificial intelligence (“AI”) business unit, led by Chief Technology & AI Officer Christopher Thurston, to integrate the Company’s existing and planned AI applications into the Co-Dx\u2122 Primer Ai\u2122 platform. Co-Dx anticipates that allocating resources to the newly formed AI business unit will enable the Company to develop proprietary AI-powered diagnostics more efficiently and … <\/p>\n

Continue reading “Co-Diagnostics to Integrate and Implement Proprietary Artificial Intelligence Technology into Co-Dx\u2122 Primer Ai\u2122 Platform”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-904356","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nCo-Diagnostics to Integrate and Implement Proprietary Artificial Intelligence Technology into Co-Dx\u2122 Primer Ai\u2122 Platform - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/co-diagnostics-to-integrate-and-implement-proprietary-artificial-intelligence-technology-into-co-dx-primer-ai-platform\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Co-Diagnostics to Integrate and Implement Proprietary Artificial Intelligence Technology into Co-Dx\u2122 Primer Ai\u2122 Platform - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire Company forms new AI business unit, led by Chief Technology & AI Officer Christopher Thurston, to unify and advance Co-Dx’s existing and future AI initiatives SALT LAKE CITY , Nov. 3, 2025 \/PRNewswire\/ — Co-Diagnostics, Inc.\u00a0(Nasdaq: CODX) (the “Company” or “Co-Dx”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced the formation of a newly organized, artificial intelligence (“AI”) business unit, led by Chief Technology & AI Officer Christopher Thurston, to integrate the Company’s existing and planned AI applications into the Co-Dx\u2122 Primer Ai\u2122 platform. Co-Dx anticipates that allocating resources to the newly formed AI business unit will enable the Company to develop proprietary AI-powered diagnostics more efficiently and … Continue reading "Co-Diagnostics to Integrate and Implement Proprietary Artificial Intelligence Technology into Co-Dx\u2122 Primer Ai\u2122 Platform"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/co-diagnostics-to-integrate-and-implement-proprietary-artificial-intelligence-technology-into-co-dx-primer-ai-platform\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-03T16:35:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/1856437\/Co_Diagnostics_New_Logo_v1.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/co-diagnostics-to-integrate-and-implement-proprietary-artificial-intelligence-technology-into-co-dx-primer-ai-platform\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/co-diagnostics-to-integrate-and-implement-proprietary-artificial-intelligence-technology-into-co-dx-primer-ai-platform\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Co-Diagnostics to Integrate and Implement Proprietary Artificial Intelligence Technology into Co-Dx\u2122 Primer Ai\u2122 Platform\",\"datePublished\":\"2025-11-03T16:35:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/co-diagnostics-to-integrate-and-implement-proprietary-artificial-intelligence-technology-into-co-dx-primer-ai-platform\\\/\"},\"wordCount\":765,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/co-diagnostics-to-integrate-and-implement-proprietary-artificial-intelligence-technology-into-co-dx-primer-ai-platform\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1856437\\\/Co_Diagnostics_New_Logo_v1.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/co-diagnostics-to-integrate-and-implement-proprietary-artificial-intelligence-technology-into-co-dx-primer-ai-platform\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/co-diagnostics-to-integrate-and-implement-proprietary-artificial-intelligence-technology-into-co-dx-primer-ai-platform\\\/\",\"name\":\"Co-Diagnostics to Integrate and Implement Proprietary Artificial Intelligence Technology into Co-Dx\u2122 Primer Ai\u2122 Platform - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/co-diagnostics-to-integrate-and-implement-proprietary-artificial-intelligence-technology-into-co-dx-primer-ai-platform\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/co-diagnostics-to-integrate-and-implement-proprietary-artificial-intelligence-technology-into-co-dx-primer-ai-platform\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1856437\\\/Co_Diagnostics_New_Logo_v1.jpg\",\"datePublished\":\"2025-11-03T16:35:01+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/co-diagnostics-to-integrate-and-implement-proprietary-artificial-intelligence-technology-into-co-dx-primer-ai-platform\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/co-diagnostics-to-integrate-and-implement-proprietary-artificial-intelligence-technology-into-co-dx-primer-ai-platform\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/co-diagnostics-to-integrate-and-implement-proprietary-artificial-intelligence-technology-into-co-dx-primer-ai-platform\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1856437\\\/Co_Diagnostics_New_Logo_v1.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1856437\\\/Co_Diagnostics_New_Logo_v1.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/co-diagnostics-to-integrate-and-implement-proprietary-artificial-intelligence-technology-into-co-dx-primer-ai-platform\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Co-Diagnostics to Integrate and Implement Proprietary Artificial Intelligence Technology into Co-Dx\u2122 Primer Ai\u2122 Platform\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Co-Diagnostics to Integrate and Implement Proprietary Artificial Intelligence Technology into Co-Dx\u2122 Primer Ai\u2122 Platform - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/co-diagnostics-to-integrate-and-implement-proprietary-artificial-intelligence-technology-into-co-dx-primer-ai-platform\/","og_locale":"en_US","og_type":"article","og_title":"Co-Diagnostics to Integrate and Implement Proprietary Artificial Intelligence Technology into Co-Dx\u2122 Primer Ai\u2122 Platform - Market Newsdesk","og_description":"PR Newswire Company forms new AI business unit, led by Chief Technology & AI Officer Christopher Thurston, to unify and advance Co-Dx’s existing and future AI initiatives SALT LAKE CITY , Nov. 3, 2025 \/PRNewswire\/ — Co-Diagnostics, Inc.\u00a0(Nasdaq: CODX) (the “Company” or “Co-Dx”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced the formation of a newly organized, artificial intelligence (“AI”) business unit, led by Chief Technology & AI Officer Christopher Thurston, to integrate the Company’s existing and planned AI applications into the Co-Dx\u2122 Primer Ai\u2122 platform. Co-Dx anticipates that allocating resources to the newly formed AI business unit will enable the Company to develop proprietary AI-powered diagnostics more efficiently and … Continue reading \"Co-Diagnostics to Integrate and Implement Proprietary Artificial Intelligence Technology into Co-Dx\u2122 Primer Ai\u2122 Platform\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/co-diagnostics-to-integrate-and-implement-proprietary-artificial-intelligence-technology-into-co-dx-primer-ai-platform\/","og_site_name":"Market Newsdesk","article_published_time":"2025-11-03T16:35:01+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/1856437\/Co_Diagnostics_New_Logo_v1.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/co-diagnostics-to-integrate-and-implement-proprietary-artificial-intelligence-technology-into-co-dx-primer-ai-platform\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/co-diagnostics-to-integrate-and-implement-proprietary-artificial-intelligence-technology-into-co-dx-primer-ai-platform\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Co-Diagnostics to Integrate and Implement Proprietary Artificial Intelligence Technology into Co-Dx\u2122 Primer Ai\u2122 Platform","datePublished":"2025-11-03T16:35:01+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/co-diagnostics-to-integrate-and-implement-proprietary-artificial-intelligence-technology-into-co-dx-primer-ai-platform\/"},"wordCount":765,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/co-diagnostics-to-integrate-and-implement-proprietary-artificial-intelligence-technology-into-co-dx-primer-ai-platform\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1856437\/Co_Diagnostics_New_Logo_v1.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/co-diagnostics-to-integrate-and-implement-proprietary-artificial-intelligence-technology-into-co-dx-primer-ai-platform\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/co-diagnostics-to-integrate-and-implement-proprietary-artificial-intelligence-technology-into-co-dx-primer-ai-platform\/","name":"Co-Diagnostics to Integrate and Implement Proprietary Artificial Intelligence Technology into Co-Dx\u2122 Primer Ai\u2122 Platform - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/co-diagnostics-to-integrate-and-implement-proprietary-artificial-intelligence-technology-into-co-dx-primer-ai-platform\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/co-diagnostics-to-integrate-and-implement-proprietary-artificial-intelligence-technology-into-co-dx-primer-ai-platform\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1856437\/Co_Diagnostics_New_Logo_v1.jpg","datePublished":"2025-11-03T16:35:01+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/co-diagnostics-to-integrate-and-implement-proprietary-artificial-intelligence-technology-into-co-dx-primer-ai-platform\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/co-diagnostics-to-integrate-and-implement-proprietary-artificial-intelligence-technology-into-co-dx-primer-ai-platform\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/co-diagnostics-to-integrate-and-implement-proprietary-artificial-intelligence-technology-into-co-dx-primer-ai-platform\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/1856437\/Co_Diagnostics_New_Logo_v1.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/1856437\/Co_Diagnostics_New_Logo_v1.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/co-diagnostics-to-integrate-and-implement-proprietary-artificial-intelligence-technology-into-co-dx-primer-ai-platform\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Co-Diagnostics to Integrate and Implement Proprietary Artificial Intelligence Technology into Co-Dx\u2122 Primer Ai\u2122 Platform"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/904356","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=904356"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/904356\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=904356"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=904356"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=904356"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}